Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, E Vilaplana, M Carmona-Iragui, B Benejam, L Videla, I Barroeta, ... The Lancet 395 (10242), 1988-1997, 2020 | 225 | 2020 |
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease D Alcolea, P Martínez-Lage, P Sánchez-Juan, J Olazarán, C Antúnez, ... Neurology 85 (7), 626-633, 2015 | 170 | 2015 |
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ... The Lancet Neurology 17 (10), 860-869, 2018 | 169 | 2018 |
Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease J Fortea, E Vilaplana, D Alcolea, M Carmona‐Iragui, ... Annals of neurology 76 (2), 223-230, 2014 | 137 | 2014 |
Cortical microstructural changes along the Alzheimer's disease continuum V Montal, E Vilaplana, D Alcolea, J Pegueroles, O Pasternak, ... Alzheimer's & Dementia 14 (3), 340-351, 2018 | 130 | 2018 |
Alzheimer's disease associated with Down syndrome: a genetic form of dementia J Fortea, SH Zaman, S Hartley, MS Rafii, E Head, M Carmona-Iragui The Lancet Neurology 20 (11), 930-942, 2021 | 128 | 2021 |
Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease D Alcolea, M Carmona-Iragui, M Suárez-Calvet, MB Sánchez-Saudinós, ... Journal of Alzheimer's Disease 42 (1), 157-167, 2014 | 128 | 2014 |
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome ED Hamlett, EJ Goetzl, A Ledreux, V Vasilevko, HA Boger, A LaRosa, ... Alzheimer's & Dementia 13 (5), 541-549, 2017 | 119 | 2017 |
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls F Sampedro, E Vilaplana, MJ De Leon, D Alcolea, J Pegueroles, V Montal, ... Oncotarget 6 (29), 26663, 2015 | 104 | 2015 |
Longitudinal brain structural changes in preclinical Alzheimer's disease J Pegueroles, E Vilaplana, V Montal, F Sampedro, D Alcolea, ... Alzheimer's & Dementia 13 (5), 499-509, 2017 | 100 | 2017 |
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease D Alcolea, E Vilaplana, J Pegueroles, V Montal, P Sánchez-Juan, ... Neurobiology of aging 36 (6), 2018-2023, 2015 | 97 | 2015 |
Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey A Hüls, ACS Costa, M Dierssen, RA Baksh, S Bargagna, NT Baumer, ... EClinicalMedicine 33, 2021 | 95 | 2021 |
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors RK Powers, R Culp-Hill, MP Ludwig, KP Smith, KA Waugh, R Minter, ... Nature communications 10 (1), 4766, 2019 | 79 | 2019 |
Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders C Delaby, D Alcolea, M Carmona-Iragui, I Illán-Gala, ... Scientific reports 10 (1), 9161, 2020 | 75 | 2020 |
Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study J Pegueroles, A Jiménez, E Vilaplana, V Montal, M Carmona-Iragui, ... Oncotarget 9 (78), 34691, 2018 | 75 | 2018 |
Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain D Alcolea, P Martínez-Lage, A Izagirre, M Clerigué, M Carmona-Iragui, ... Journal of Alzheimer's Disease 39 (4), 719-726, 2014 | 75 | 2014 |
Association of Alzheimer disease with life expectancy in people with Down syndrome MF Iulita, DG Chavez, MK Christensen, NV Tamayo, O Plana-Ripoll, ... JAMA network open 5 (5), e2212910-e2212910, 2022 | 67 | 2022 |
Prevalence of sleep disorders in adults with down syndrome: a comparative study of self-reported, actigraphic, and polysomnographic findings S Giménez, L Videla, S Romero, B Benejam, S Clos, S Fernández, ... Journal of Clinical Sleep Medicine 14 (10), 1725-1733, 2018 | 67 | 2018 |
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: a data set for biomarker discovery and validation in neurodegenerative disorders D Alcolea, J Clarimón, M Carmona-Iragui, I Illán-Gala, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 64 | 2019 |
Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease A Jimenez, J Pegueroles, M Carmona-Iragui, E Vilaplana, V Montal, ... Oncotarget 8 (62), 104706, 2017 | 63 | 2017 |